Delayed
Japan Exchange
01:30:00 2026-01-16 am EST
5-day change
1st Jan Change
1,321.00 JPY
+0.38%
+3.04%
+5.68%
Published on 01/15/2026
at 07:18 pm EST
Publicnow
+0.38%
Nissha Co., Ltd. (hereinafter “Nissha”) has obtained certification under the Medical Device Single Audit Program (MDSAP) for its manufacturing site at the Global Headquarters in Kyoto.
Nissha brings together diverse technologies and human capabilities to address global challenges in the medical, mobility, and sustainable materials, aiming to create both economic and social value. In the medical segment, we are actively expanding our business, with our Global Headquarters in Kyoto serving as a key manufacturing site for medical devices for the Japanese and North American markets.
MDSAP (Medical Device Single Audit Program) is an international audit program that integrates regulatory requirements from five participating countries-the United States, Canada, Brazil, Australia, and Japan-allowing medical device manufacturers to demonstrate compliance with multiple countries’ quality management system standards through a single audit. This program streamlines audits, enhances global competitiveness, and reduces costs compared to separate country-specific inspections.
Our Global Headquarters has already established a robust quality management system, including ISO 13485:2016 certification. With the acquisition of MDSAP certification, we are now better positioned to serve the North American market and further strengthen our global OEM medical device manufacturing capabilities.
Related Information
Nissha Obtains ISO 13485 (Quality Management System for Medical Devices) Certification for Global Headquarters in Kyoto
Attachments
Original documentPermalink
Disclaimer
Nissha Co. Ltd. published this content on January 16, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 16, 2026 at 00:17 UTC.
Nov. 21
Nissha Co Ltd – announces cancellation of treasury shares
RE
Nov. 11
Nissha Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2025
CI
25-08-06
Nissha Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending December 31, 2025
CI
25-08-06
Nissha Co., Ltd. Announces Dividend for the Second Quarter Ended June 30, 2025, Payable on September 1, 2025
CI
25-05-09
Nissha Co., Ltd. Provides cash Dividend Guidance for the Second Quarter 2025 and Fiscal Year Ending December 31, 2025
CI
25-05-09
Nissha Co., Ltd. Provides Earnings Guidance for the First Half 2025 and Fiscal Year Ending December 31, 2025
CI
25-03-25
Tranche Update on Nissha Co., Ltd.’s Equity Buyback Plan announced on November 8, 2024.
CI
25-03-23
Nissha Co., Ltd.’s Equity Buyback announced on November 8, 2024, has closed with 600,000 shares, representing 1.26% for ¥922.50 million.
CI
25-01-28
Blue Ocean Closures AB announced that it has received funding from Nissha Co., Ltd.
CI
25-01-08
Tranche Update on Nissha Co., Ltd.’s Equity Buyback Plan announced on November 8, 2024.
CI
24-12-23
Nissha Co., Ltd. agreed to acquire Shigaken Pharm,Ind.Co.,Ltd.
CI
24-11-08
Nissha Co., Ltd. announces an Equity Buyback for 600,000 shares, for ¥1,000 million.
CI
24-11-07
Nissha Co., Ltd. authorizes a Buyback Plan.
CI
24-09-20
Tranche Update on Nissha Co., Ltd.’s Equity Buyback Plan announced on August 6, 2024.
CI
24-09-18
Nissha Co., Ltd.’s Equity Buyback announced on August 6, 2024, has closed with 501,900 shares, representing 1.04% for ¥999.94 million.
CI
24-08-06
Nissha Co., Ltd. announces an Equity Buyback for 600,000 shares, representing 1.24% for ¥1,000 million.
CI
24-08-05
Nissha Co., Ltd. authorizes a Buyback Plan.
CI
24-04-11
Jefferies Starts Nissha at Buy With 3,170 Yen Price Target
MT
24-02-02
Tranche Update on Nissha Co., Ltd.’s Equity Buyback Plan announced on November 9, 2023.
CI
24-01-31
Nissha Co., Ltd’s Equity Buyback announced on November 9, 2023, has closed with 653,800 shares, representing 1.34% for ¥999.94 million.
CI
24-01-12
Tranche Update on Nissha Co., Ltd.’s Equity Buyback Plan announced on November 9, 2023.
CI
23-11-09
Nissha Co., Ltd. announces an Equity Buyback for 700,000 shares, representing 1.43% for ¥1,000 million.
CI
23-11-08
Nissha Co., Ltd. authorizes a Buyback Plan.
CI
23-05-11
Nissha Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
23-03-14
Tranche Update on Nissha Co., Ltd.’s Equity Buyback Plan announced on November 10, 2022.
CI
DurationAuto.2 months3 months6 months9 months1 year2 years5 years10 yearsMax.
PeriodDayWeek
7915: Dynamic Chart
Nissha Co.,Ltd., is a Japan-based company mainly engaged in the planning, development, production and sale of industrial materials, devices, medical technology, information and communication and others. It operates through four business segments. Industrial Materials segment produces and sells decorative films, molds, molded product and metallized paper. Device segment is engaged in manufacture and sale of film touch sensors, gas sensors and input devices. Medical Technology segment is engaged in the production and sale of medical electrodes and surgical instruments for medical institutions, and the contract manufacturing for medical device manufacturers. Information Communication segment is involved in the planning, production and sale of products and services such as publication printing, commercial printing, art solutions, and sales promotions. It is also engaged in the business of green space management, industrial waste separation collection and transportation, and security.
More about the company
Sell
Buy
Last Close Price
1,316.00JPY
Average target price
1,420.00JPY
Spread / Average Target
+7.90%
Consensus
OUR EXPERTS ARE HERE FOR YOU
Monday – Friday 9am-12pm / 2pm-6pm GMT + 1
Select your edition
All financial news and data tailored to specific country editions
AloJapan.com